Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
45
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Precision Drilling
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
US Gas Basins And LNG Canada Will Drive High-Efficiency Drilling
Key Takeaways Precision is poised for above-peer growth and utilization due to strong customer demand, technological upgrades, and superior operator relationships in both the U.S. and Canada. Demand for high-spec, lower-emission rigs and global supply constraints position Precision for premium pricing, robust margins, and enduring long-term earnings strength.
View narrative
CA$119.48
FV
37.7% undervalued
intrinsic discount
1.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Organización Soriana S. A. B. de C. V
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Mexico's Middle Class And Digital Retail Will Reshape Consumer Demand
Key Takeaways Strategic investment in private label, digital sales, and loyalty programs will boost growth, margins, and long-term customer engagement. Expansion into new store formats and the home improvement segment diversifies revenue and strengthens operating leverage despite market pressures.
View narrative
Mex$32.92
FV
23.3% undervalued
intrinsic discount
7.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
LifeMD
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Expanding Care Domains And Telemedicine Will Unlock New Markets
Key Takeaways Expansion into new care areas and insurance partnerships broadens market reach, reduces concentration risk, and supports stability in patient acquisition and revenue. Enhanced AI integration and the subscription-based care model improve operational efficiency, patient retention, and margin growth through automation and recurring revenue streams.
View narrative
US$12.88
FV
50.1% undervalued
intrinsic discount
14.64%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
2 days ago
author updated this narrative
Toast
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Integrated Digital Payments And Automation Will Unlock Future Opportunities
Key Takeaways Expanding digital solutions and automation drive increased market share, recurring revenues, and operational efficiency for restaurants upgrading from legacy systems. New market entries, product upselling, and strategic partnerships diversify revenue streams and deepen customer loyalty, boosting earnings resilience.
View narrative
US$50.33
FV
14.3% undervalued
intrinsic discount
17.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
45
users have followed this narrative
3 days ago
author updated this narrative
Iovance Biotherapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Oncology Expansion And Global Approvals Will Unlock Future Markets
Key Takeaways Expanded distribution and positive clinical data are set to boost adoption of Amtagvi and strengthen revenue growth in oncology markets. Operational streamlining, new pipeline advancements, and global expansion efforts are expected to improve profitability and diversify long-term earnings.
View narrative
US$10.00
FV
74.5% undervalued
intrinsic discount
45.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
59
users have followed this narrative
Updated
narrative
Rocket Lab
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Integrated Space Capabilities Will Capture National Security Contracts
Key Takeaways Expanded vertical integration and end-to-end space solutions position Rocket Lab for major defense contracts and future margin growth. High launch cadence, satellite manufacturing, and reusable rocket development enable multi-year revenue growth, backlog expansion, and broader market access.
View narrative
US$45.40
FV
2.5% undervalued
intrinsic discount
37.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
185
users have followed this narrative
3 days ago
author updated this narrative
Allbirds
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Sustainable Footwear Launches And Distributor Shift Will Expand Future Presence
Key Takeaways New product innovations, sustainable material partnerships, and refreshed marketing are set to boost brand appeal, customer engagement, and support higher pricing. Shifting to a distributor model and strict cost management are expected to enhance profitability, free up capital, and widen margins despite short-term challenges.
View narrative
US$11.00
FV
36.1% undervalued
intrinsic discount
3.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
Cytosorbents
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
FDA And Health Canada Approval Will Spur ICU Solutions
Key Takeaways Increasing adoption of blood purification therapies, supported by clinical evidence and hospital cost savings, drives long-term revenue and margin expansion opportunities. Regulatory approvals and operational improvements position the company for accelerated growth in key markets and sustainable progress toward profitability.
View narrative
US$5.00
FV
76.8% undervalued
intrinsic discount
27.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Tigo Energy
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
EMEA Expansion And Grid Modernization Will Empower Future Success
Key Takeaways Expansion into supportive international markets and regulatory tailwinds for solar safety drive revenue growth, market share gains, and gross margin improvement. Operational discipline and resolved supply chain issues support profitability trends and stronger cash flow amid robust demand for core products.
View narrative
US$4.63
FV
73.0% undervalued
intrinsic discount
37.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies